Interferon-Alpha, Bcl-2 Expression and Apoptosis in B-Cell Chronic Lymphocytic Leukemia

References

• De Maeyer, E. and De Maeyer-Guignard, J. (1988) Interferons and other regulatory cytokines. John Wiley & Sons New York.
   Google Scholar
• Goldstein, D. and Laszlo, J. (1986) Interferon therapy in cancer: from imagination to interferon. Cancer Research, 46,4315–4329.
   PubMed Web of Science ®Google Scholar
• Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M., and Gutterman, J. U. (1984) Alpha interferon for the induction of re-mission in hairy cell leukemia. New England Journal of Medicine, 310, 15–18.
   PubMed Web of Science ®Google Scholar
• Galvani, D. W. and Cawley, J. C. (1990) The current status of in-terferon-alpha in haemic malignancy. Blood Reviews, 4, 175–180.
   PubMed Web of Science ®Google Scholar
• Heslop, H. E. and Hoffbrand, A. V. (1992) Interferons in haemato-logical malignancy. Recent Advances in Haematology, 7, 131–148.
   Google Scholar
• Foon, K. A., Bottino, G. C., Abrams, P. G., Fer, M. F., Longo, D. L., Schoenberger, C. S., and Oldham, R. K. (1985) Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia. American Journal of Medicine, 78, 216–220.
   PubMed Web of Science ®Google Scholar
• Pangalis, G. A. and Griva, E. (1988) Recombinant alfa 2b interferon therapy in untreated stages A and B chronic lymphocytic leukemia. Cancer, 61, 869–872.
   PubMed Web of Science ®Google Scholar
• Rozman, C., Montserrat, E., Vinolas, N., Urbano-Ispizua, A., Ribera, J. M., Gallart, T., and Compernolle, C. (1988) Recombinant alpha 2 interferon in the treatment of chronic lymphocytic leukemia in early stages. Blood, 71, 1355–1360.
   Google Scholar
• McSweeney, E. N., Giles, F. J., Woman, C. P., Jewell, A. P., Tsakona, C. P., Hoffbrand, A. V., Mehta, A. B., Newland, A. C., and Goldstone, A. H. (1993) Recombinant alfa 2a interferon ther-apy in the treatment of patients with early stage B chronic lymphatic leukaemia. British Journal of Haematology, 85,77–83.
   PubMed Web of Science ®Google Scholar
• Heslop, H. E., Bianchi, A. C. M., Cordingley, F. T., Turner, M., De Mel, C. P., Hoffbrand, A. V:, and Brenner, M. K. (1990) Effects of interferon-alpha on autocrine growth factor loops in B lymphopro-liferative disorders. Journal of Experimental Medicine, 172, 1729–1734.
   Google Scholar
• Hoffbrand, A. V., Panayiotidis, P., Reittie, J., and Ganeshaguru, K. (1993) Autocrine and paracrine growth loops in chronic lympho-cytic leukemia. Seminars in Haematology, 30, 306–317.
   PubMed Web of Science ®Google Scholar
• Ostlund, L., Einhorn, S., Robert, K-H., Juliusson, G., and Biberfeld, P. (1985) Chronic B-lymphocytic leukaemia cells proliferate and differentiate following exposure to interferon in vitro. Blood, 67, 152–159.
   Google Scholar
• Drexler, H. G. (1988) Which cells do respond during in vitro stim-ulation of B-CLL and HCL cultures? Leukaemia, 4,240–241.
   Google Scholar
• Totterman, T., Carlsson, M., and Nilsson, K. (1988) Induction of IgM secretion in chronic lymphocytic leukaemia cells in serum free medium: Effects on interferon-alpha, -gamma and phorbol ester. Clinical and Experimental Immunology, 71, 187–192.
   PubMed Web of Science ®Google Scholar
• Nossal, G. V. (1983) Cellular mechanisms of immunologic toler-ance. Annual Review of Immunology, 1, 33–62.
   PubMed Web of Science ®Google Scholar
• Jewell, A. P., Yong, K. L., Worman, C. P., Giles, F. J., Goldstone, A. H., and Lydyard, P. M. (1992) Cytokine induction of leucocyte adhesion molecule-1 (LAM-1) on chronic lymphocytic leukaemia cells. Leukaemia, 6,400–404.
   PubMed Web of Science ®Google Scholar
• Jewell, A. P., Yong, K. L., Worman, C. P., Tsakona, C. P., Giles, F. J., and Goldstone, A. H. (1994) Serum macrophage colony stimu-lating factor (M-CSF) levels correlate with clinical response to in-terferon-alpha in patients with early stage B-CLL. British Journal of Haematology, 86,441–443.
   PubMed Web of Science ®Google Scholar
• Jewell, A. P., Worman, C. P., Giles, F. J., Goldstone, A. H., and Lydyard, P. M. (1992) Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells. Leukaemia and Lymphoma, 7,473–480.
   PubMed Web of Science ®Google Scholar
• Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. (1985) Involvement of the bet-2 gene in human follicular lymphoma. Science, 228, 1440–1443.
   PubMed Web of Science ®Google Scholar
• Cohen, J. J. (1991) Programmed cell death in the immune system. Advances in Immunology, 50, 55–85.
   PubMed Web of Science ®Google Scholar
• McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., and Korsmeyer, S. J. (1989) Bc1-2-immunoglobu-lin transgenic mice demonstrate extended B-cell survival and fol-licular lymphoproliferation. Cell, 57, 79–88.
   PubMed Web of Science ®Google Scholar
• Dighiero, G. (1993) Biology of the neoplastic lymphocyte in B-CLL. Baillieres Clinical Haematology, 6, 807–820.
   PubMed Web of Science ®Google Scholar
• Raghobier, S., van Kreiken, J. H. J. M., Kluin-Nelemans, J. C., Gillis, A., van Ommen, G. J. B., Ginsberg, A. M., Raffeld, M., and Kluin, P.M. (1991) Oncogene rearrangements in chronic B-cell leukemia. Blood, 77, 1560–1564.
   Google Scholar
• Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., and Mason, D. Y. (1990) Expression of the bc1-2 oncogene protein is not specific for the 14;18 chromosomal translocation. American Journal of Pathology, 137,225–232.
   PubMed Web of Science ®Google Scholar
• Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., and Reed, J. C. (1993) bc1-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood, 82,1820–1828.
   Google Scholar
• Liu, Y. J., Johnson, G. D., Gordon, J., and MacLennan, I. C. M. (1992) Germinal centres in T-cell-dependent antibody responses. Immunology Today, 13,17–21.
   PubMedGoogle Scholar
• Schena, M., Gottardi, D., Ghia, P., Larsson, L-G., Carlsson, M., Nilsson, K., and Caligaris-Cappio, F. (1993) The role of bc1-2 in the pathogenesis of B chronic lymphocytic leukemia. Leukemia and Lymphoma, 11, 173–179.
   Google Scholar
• Jonak, G. J. and Knight, E. (1987) Interferons and the regulation of oncogenes. Interferon, 8, 167–180.
   Google Scholar
• Foon, K. A., Rai, K. R., and Gale, R. P. (1990) Chronic lympho-cytic leukaemia: new insights into biology and therapy. Annals of Internal Medicine, 113, 525–539.
   PubMed Web of Science ®Google Scholar
• Collins, R. J., Verschuer, L. A., Harrnon, B. V., Prentice, R. L., Pope, J. H., and Kerr, J. F. R. (1989) Spontaneous programmed cell death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. British Journal of Haematology, 71, 343–350.
   PubMed Web of Science ®Google Scholar
• Nunez, G., London, L., Hockenbury, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. (1990) Deregulated bc1-2 expression se-lectively prolongs survival of growth factor dependent hemopoietic cell lines. Journal of Immunology, 144, 3602–3610.
   PubMed Web of Science ®Google Scholar
• Jewell, A. P., Lydyard, P. M., Worman, C. P., Giles, F. J., and Goldstone, A. H. (1994) Growth factors can protect B-chronic lym-phocytic leukemia cells against programmed cell death without stimulating proliferation. Leukemia and Lymphoma,
   Google Scholar
• Huang, R. W., Tsuda, H., and Takatsuki, K. (1993) Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. International Journal of Hematology, 58, 83–92.
   PubMed Web of Science ®Google Scholar
• Danescu, M., Rubio-Trujillo, M., B iron, G., Delespesse, G., and Sarfati, M. (1992) Interleukin 4 protects chronic lymphocytic leukemia cells from death by apoptosis and up-regulates bc1-2 ex-pression. Journal of Experimental Medicine, 176, 1319–1326.
   PubMed Web of Science ®Google Scholar
• Panayiotidis, P., Gareshaguru, K., Jabbar, S. A., and Hoffbrand, A. V. (1993) Interleukin 4 inhibits apoptotic cell death and loss of the bc1-2 protein in B-chronic lymphocytic leukemia cells in vitro. British Journal of Haematology, 85, 439–445.
   PubMed Web of Science ®Google Scholar
• Buschle, M., Campana, D., Carding, S. R., Richard, C., Hoffbrand, A. V., and Brenner, M. K. (1993) Interferon gamma inhibits apop-totic cell death in B cell chronic lymphocytic leukemia. Journal of experimental Medicine, 177, 213–218.
   PubMed Web of Science ®Google Scholar
• Pariayiotidis, P., Ganeshaguru, K., Jabbar, S. A., and Hoffbrand, A. V. (1994) Alpha interferon protects B-chronic lymphocytic leukemia cells from apoptotic cell death in vitro. British Journal of Haematology, 86, 169–173.
   PubMed Web of Science ®Google Scholar
• Jewell, A. P., Worman, C. P., Lydyard, P. M., Yong, K. L., Giles, F. J., and Goldstone, A. H. (1994) Interferon alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. British Journal of Haematology, 88, 268–274.
   PubMed Web of Science ®Google Scholar
• Chaouchi, N., Wallon, C., Taieb, J., Auffredou, M. T. Tertian, G., Lemoine, F. M., Delfraissy, J. F., and Vazquez, A. (1994) Interferon-alpha mediated prevention of in vitro apoptosis of chronic lympho-cytic leukaemia cells:role of bc1-2 and c-myc. Clinical Immunology and Immunopathology, 73, 197–204.
   PubMedGoogle Scholar
• Nunez, G. and Clarke, M. F. (1994) The bc1-2 family of proteins; regulators of cell death and survival. Trends in Cell Biology, 4, 399–403.
   PubMedGoogle Scholar
• Kipps, T. J., Rassenti, L. Z., Duffy, S., Kobayashi, R., Martin, T., Chen, P. P., and Carson, D. A. (1991) Immunoglobulin gene re-arrangement and expression in B-CLL. Leukaemia and lymphoma, 5 Si, 39–45.
   Google Scholar
• MacLennan, I. C. M. and Gray, D. (1986) Antigen driven selection of virgin and memory B-cells. Immunological Reviews, 91,61–86.
   Google Scholar
• Ihle, J. N. and Kerr, M. (1995) Jaks and stats in signalling by the cytokine receptor family. Trends in Genetics, 11, 69–74.
   PubMed Web of Science ®Google Scholar
• Xu, B., Grander, D., Sangfelt, 0., and Einhom, S. (1994) Primary leukaemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA binding factor interferon-stimulated gene factor 3. Blood, 84, 1942–1949.
   Google Scholar
• Fluckiger, A. C., Durand, I., and Banchereau, J. (1994) Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. Journal of Experimental Medicine, 179,91–99.
   PubMed Web of Science ®Google Scholar
• Briere, F., Bridon, J. M., Chevet, D., Souillet, G., Bienvenu, F., and Guret, C. (1994) Interleukin 10 induces B lymphocytes from IgA deficient patients to secrete IgA. Journal of Clinical Investigation, 94,97–104.
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler, T., Craig, V. A., Copplestone, J. A., Hamon, M. D., and Prentice, A. G. (1994) Interleukin 5 increases spontaneous apoptosis of B-cell chronic lymphocytic leukaemia cells in vitro in-dependently of bc1-2 expression and is inhibited by IL-4. Blood, 84, 2297–2304.
   Google Scholar
• Jewell, A. P. and Khwaja, A. (1994) Unpublished observations.
   Google Scholar